Evaluation Criteria, Diagnostic Criteria, Surgical Indications, and Establishment of Surgical Standards for "Cerebral Tinnitus Syndrome" Caused by Internal Jugular Vein Stenosis.
2 other identifiers
interventional
369
1 country
1
Brief Summary
"Cerebral Tinnitus," also known as "cranial tinnitus," refers to the patient-reported perception of intracranial sounds. It often presents as "Cerebral Tinnitus Syndrome," which includes symptoms such as tinnitus with hearing loss, headaches, a heavy head sensation, blurred vision, neck and shoulder discomfort, sleep disturbances, anxiety, and depression. Due to limited awareness of cerebral tinnitus, patients frequently seek treatment across multiple facilities without success, severely impacting their and their families' lives and work. Xunming Ji and colleagues have pointed out that cerebral tinnitus results from stenosis of the cerebral or internal jugular veins (IJVS), which impairs cerebral venous outflow and the clearance of metabolic "waste," leading to chronic metabolic damage to brain cells. Currently, studies on the diagnosis and treatment of IJVS-induced cerebral tinnitus, both domestically and internationally, are primarily case reports, lacking systematic evaluation, diagnostic, and treatment standards, which significantly impacts patient outcomes. Our project team is the first to establish evaluation criteria, diagnostic standards, surgical indications, and surgical standards for "Cerebral Tinnitus Syndrome." In preliminary work, we performed internal jugular vein (IJV) decompression on 32 cerebral tinnitus patients, resulting in an IJV morphological improvement rate of 84.3%, a blood flow improvement rate of 75.0%, and a cerebral tinnitus syndrome improvement rate of 62.5%. To date, we have completed 88 IJV decompression surgeries, making ours the largest clinical center for such cases worldwide. We continue to refine these standards, notably introducing new intraoperative standards for IJV "release" and "high perfusion,". To validate and further study these standards, this project plans to perform IJV decompression surgery on 107 cerebral tinnitus patients affected by IJVS. We aim to establish a cerebral tinnitus database and develop a cerebral tinnitus evaluation scale to standardize evaluation criteria, diagnostic standards, surgical indications, and surgical standards, ultimately advancing clinical diagnosis and treatment of Cerebral Tinnitus Syndrome
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 7, 2025
CompletedFirst Submitted
Initial submission to the registry
April 24, 2026
CompletedFirst Posted
Study publicly available on registry
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2030
May 1, 2026
May 1, 2025
4.7 years
April 24, 2026
April 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cerebral tinnitus improvement rate at 3 months postoperatively
Assessed by VAS score (0-10). Improvement defined as: Marked improvement: ≥30% reduction in VAS Mild improvement: 10%-30% reduction No obvious change: 0%-10% reduction Aggravation: increased VAS
3 months postoperatively
Secondary Outcomes (5)
Cerebral tinnitus improvement rate at 12 months postoperatively
12 months postoperatively
Improvement rate of other clinical symptoms at 3 and 12 months postoperatively
3 and 12 months postoperatively
Morphological improvement of the internal jugular vein (IJV) postoperatively
3 and 12 months postoperatively
Blood flow recovery of IJV postoperatively
3 and 12 months postoperatively
Safety outcomes
3 and 12 months postoperatively
Study Arms (1)
Surgical Intervention Group
EXPERIMENTALInternal Jugular Vein Decompression is a surgical procedure designed to relieve stenosis or external compression of the internal jugular vein, restore normal cerebral venous outflow, and alleviate symptoms related to chronic venous congestion such as pulsatile tinnitus (tinnitus cerebri), positional headache, and visual disturbances.It can be performed via open surgical decompression (releasing surrounding soft tissue/bony compression) or endovascular intervention (balloon angioplasty/stenting) to treat significant jugular vein stenosis refractory to medical management.
Interventions
This surgical procedure is performed with the patient in the lateral decubitus position (affected side up), under electrophysiological monitoring of the sternocleidomastoid and trapezius muscles. A 3-4 cm straight incision is made below the mastoid tip, and the atlas transverse process is exposed via careful dissection along the anterior border of the sternocleidomastoid muscle while preserving the cervical branch of the facial nerve. Under endoscopy and microscopy, the anterolateral portion of the transverse process is thoroughly drilled using diamond burrs (4 mm and 2 mm) according to preoperative CTV measurements. After bone resection, the carotid sheath is opened to expose the internal jugular vein (IJV), and perivascular soft tissues are fully released over a width of more than 2 cm to decompress the entire J3 segment of the IJV. Subsequently, the systolic blood pressure is elevated by at least 20% above baseline and maintained for 30 minutes to achieve IJV hyperperfusion and prom
Eligibility Criteria
You may qualify if:
- Age between 18 and 75 years, with no gender restriction.
- Presence of one or more symptoms associated with "Cerebral Tinnitus Syndrome," with a duration of at least 3 months.
- Following a detailed medical history and comprehensive physical examination, other known causes of cerebral tinnitus are preliminarily excluded, with suspected internal jugular vein stenosis (IJVS) as the cause.
- Imaging studies (e.g., jugular ultrasound, cervical venous CT venography (CTV)) show significant stenosis in the internal jugular vein (stenosis degree ≥50%).
- The patient has provided informed consent and voluntarily agrees to participate in the study, with a signed informed consent form.
You may not qualify if:
- Patients with a history of cranial surgery or diagnosed intracranial space-occupying lesions.
- Patients with severe cardiac, hepatic, or renal insufficiency, or other systemic diseases.
- Patients who have undergone any surgical or interventional procedures affecting jugular venous flow within the last 6 months.
- Patients with a history of psychiatric disorders or cognitive impairment who cannot complete study evaluations.
- Pregnant or breastfeeding women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Shijitan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100038, China
Related Publications (1)
Li M, Sun Y, Chan CC, Fan C, Ji X, Meng R. Internal jugular vein stenosis associated with elongated styloid process: five case reports and literature review. BMC Neurol. 2019 Jun 4;19(1):112. doi: 10.1186/s12883-019-1344-0.
PMID: 31164090BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2026
First Posted
May 1, 2026
Study Start
May 7, 2025
Primary Completion (Estimated)
December 30, 2029
Study Completion (Estimated)
December 30, 2030
Last Updated
May 1, 2026
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- The IPD and related supporting information will be made available \*\*starting from the date of study completion\*\*, and will remain accessible for \*\*5 years after the end of the study\*\*.
- Access Criteria
- Clinical Study Report (CSR)
Baseline demographic data (age, gender, body mass index, medical history). Preoperative and postoperative VAS scores for tinnitus cerebri and other clinical symptoms at 3 and 12 months. Imaging measurements: IJV diameter on CTV at the decompressed segment pre- and postoperatively. Hemodynamic data: blood flow velocity of the IJV J3 segment measured by Doppler ultrasound. Safety data: occurrence, time, and severity of adverse events and serious adverse events. Data will be shared after de-identification, without exposing participant privacy or protected health information.